Table 2.
Frequency of events detected by the software as CK-PE+ and DAPI+ that were not classified as CTC in 7.5 mL of blood from normal donors: patients with benign disease, and metastatic breast, colorectal and prostate cancer patients before initiation of a new line therapy.
| CTC | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | ≥1–<5 | ≥5 | ||||||||||
| n | mean | SD | med | n | mean | SD | med | n | mean | SD | Med | |
| Normal | 285 | 53 | 68 | 40 | 10 | 81 | 108 | 42 | 0 | — | — | — |
| Benign | 236 | 38 | 30 | 30 | 18 | 44 | 26 | 47 | 1 | 159 | — | 159 |
| Breast | 50 | 53 | 29 | 29 | 36 | 73 | 93 | 38 | 86 | 403 | 1182 | 84 |
| Colorectal | 217 | 223 | 1070 | 78 | 121 | 266 | 468 | 116 | 75 | 603 | 1620 | 230 |
| Prostate | 49 | 420 | 1713 | 86 | 44 | 222 | 358 | 101 | 125 | 1301 | 3020 | 412 |